5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18270808 | A BISPECIFIC ANTIBODY TARGETING GPC3 AND CD47 | GODDARD, LAURA B | 1642 | Non-Final OA | Jul 03, 2023 |
| 17935400 | ANTIBODIES AGAINST AREG AND ITS USE | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Sep 26, 2022 |
| 17813157 | SPECIFIC HOST FACTOR OF HEPATITIS B VIRUS INFECTION, AND USE THEREOF | ZOU, NIANXIANG | 1671 | Non-Final OA | Jul 18, 2022 |
| 17614673 | DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Final Rejection | Nov 29, 2021 |
| 17614737 | ANIMAL MODEL OF IDIOPATHIC PULMONARY FIBROSIS, ITS CONSTRUCTION METHOD AND USE | DHAR, MATASHA | 1632 | Final Rejection | Nov 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial